Skip to main content

Revance Therapeutics, Inc. (NASDAQ: RVNC) Investor Securities Class Action Lawsuit 12/10/2021

  • If you purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 2019 and October 11, 2021, and / or if you purchased any NASDAQ: RVNC shares prior to November 2019 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 7, 2022 - An amended complaint was filed. December 10, 2021 - An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between Nov...



You must register (for free) or login to view the entire case.